Why Wall Street Is Piling Into the "Debasement Trade"

Wall Street has been making headlines lately for piling into a strange new money move. What they've dubbed the "Debasement Trade"... And it could affect you and your money in a MAJOR way. Dr. David Eifrig's latest warning deserves your attention.

Clearmind Medicine (CMND) Stock Soars Thursday: What's Going On?

Evette Mitkov
November 13, 2025

Clearmind Medicine Inc (NASDAQ:CMND) shares are trading higher on Thursday. The company reported that Hadassah Medical Center in Jerusalem has given its final approval for an ongoing Phase 1/2a clinical trial, which is assessing CMND-100’s potential to treat alcohol use disorder (AUD).

  • CMND is delivering impressive returns. See what is driving the move here.

What To Know: The clinical-stage biotech company’s CMND-100 is a proprietary MEAI-based oral drug candidate. Clearmind received final approval for its ongoing Phase 1/2a clinical trial evaluating CMND-100 for the treatment of AUD.

The first cohort treatment of Clearmind’s clinical trial was successfully completed. The approval enables Hadassah Medical Center to join the company’s clinical trial.

The Yale School of Medicine’s Department of Psychiatry, Johns Hopkins University School of Medicine, and Israel’s Tel Aviv Sourasky Medical Center are among the other institutions taking part in the trial. The study at Hadassah-University Medical Center will be supervised by Joseph Caraco, the director of the clinical pharmacology unit in the medical department.

The Phase 1/2a clinical trial is a multinational, multi-center investigation intended to assess the pharmacokinetic profile, safety and tolerability of CMND-100. Additionally, the study will gauge its initial success in lowering alcohol consumption and cravings in patients with alcohol use disorder.

According to the World Health Organization, AUD causes 4.7% of all deaths globally; Clearmind’s trial aims to address this issue. With the goal of providing a ground-breaking solution for those impacted by AUD and their families, the company expects to make additional steps in patient enrollment and data collection throughout its clinical site.

CMND Price Action: Clearmind shares were up 18.05%, trading at approximately 37 cents at the time of publication on Thursday, according to Benzinga Pro. Operating in the pharmaceutical industry, Clearmind Medicine’s 52-week range shows notable volatility, peaking at $2.18, indicating a high level of investor speculation or interest in the company’s potential for growth.

Read Next:

  • Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

Image: Bigc Studio/Shutterstock.com

Continue Reading...

Popular

IRS boosts contribution limits for 401(k) retirement plan savers

Americans will be allowed to contribute more of their money to 401(k) and similar retirement saving plans next year.

Serve Robotics Shares Skid: What's Going On?

Serve Robotics Inc (NASDAQ:SERV) shares are trading lower on Thursday. The company disclosed its financial results for the third quarter.

America's Next Security Revolution Has Begun - Ad

Built for endurance, powered by AI, and proven in the field, the K7 is redefining protection for ports, energy hubs, and cities across the nation. The rollout is already underway.

Home Depot Could Hammer Out Gains With Pro Expansion, Analyst Says

Bank of America expects Home Depot's Q3 earnings to show 1.3% sales increase. Analysts maintain Buy rating and $450 price forecast.

Is Floor & Decor Quietly Positioning For A 2026 Housing Upswing?

Goldman Sachs upgrades Floor & Decor Holdings to Neutral, citing potential market-share gains and improved housing conditions in 2026.

After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad

For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.

Marjorie Taylor Greene Buys Blue Chip Stock Near 52-Week Low

Marjorie Taylor Greene is known for buying multiple stocks at a time, based on recent disclosures. A new filing shows one stock bought in November.

Turkey in talks with Qatar and Oman to buy used Eurofighter jets, Erdogan says

ANKARA, Turkey (AP) — Turkey is negotiating with Qatar and Oman to acquire used Eurofighter Typhoon fighter jets as part of its effort to bolster its air force capabilities, President said in comments released Friday.

This Overlooked Memecoin Is Showing Early Breakout Signals - Ad

We've been tracking one small memecoin that checks all the boxes: strong on-chain signals, real traction, and an entry point that could offer serious upside. It's not on many radars yet-but that could change fast.

Why Airlines May Hold Pricing Power Into 2026 Even After Shutdown Disruptions

BofA Securities says US airlines are strong despite shutdown, with core demand drivers and capacity discipline supporting positive outlook.

Trump Tells Republicans To Not Be 'Weak:' 'You Will Rue The Day That You Didn't Terminate The…'

Trump urges Republicans to end filibuster and warns of Democratic plans to expand Supreme Court. Government shutdown continues.

The K7 Is Changing the Economics of Security - Ad

$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.

MSNBC's name is being replaced, but its leaders insist that its mission will remain the same

NEW YORK (AP) — Asked what viewers should expect when television's MSNBC makes its from NBC News final this weekend, network president Rebecca Kutler points to a poster on the wall of a conference room at its new offices off Times Square.

The Real Reason This Analyst Still Calls Nebius His Favorite Neocloud Player

Nebius Group (NASDAQ: NBIS) reported strong Q3 results, boosting capacity & revenue guidance through 2026. Analyst reiterated Buy rating.

Buy This Stock Tomorrow? - Ad

A renowned former hedge fund manager - friends to some of the biggest investors in the world - just released a new list of his favorite AI stocks... and not a single Magnificent 7 name made the cut. Instead, an AI stock you've likely never heard of just flagged as "near-perfect" in his new investing scoring system.

Vietnam's VinFast Hits Over 20,000 Monthly EV Deliveries

VinFast delivered a record 20,380 EVs in Vietnam in October—first local maker to top 20k in a month—even as shares dipped.

A Low-Profile Memecoin Is Quietly Gaining Serious Momentum - Ad

While everyone's watching the big-name coins, a lesser-known memecoin is gathering speed. With unique utility, a growing user base, and strong chart signals, our research team believes this could be a breakout waiting to happen.

Time To Sell XRP? These 3 Indicators Scream 'Take Profits'

XRP (CRYPTO: XRP) fell below key moving averages on Wednesday, signaling fading bullish momentum as multiple indicators flashed a strong sell warning.

A Vermont cycling apparel company is trying to survive Trump's tariffs. Will the Supreme Court help?

BURLINGTON, Vt. (AP) — From the moment President Donald Trump on nearly every country, Nik Holm feared the company he leads might not survive.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

Tesla's First Semi Vehicle Customer After Full Production Launch Is….Tesla?

Tesla Semi is one of several vehicles set for full-scale production in 2026 from Tesla. Here's the company's first major customer.

Visa Launches Stablecoin Payouts For The Gig Economy As Traders Eye $343

Visa Inc. (NYSE:V) is shaking up digital payments with a new pilot program that lets creators, freelancers, and gig workers receive instant USDC stablecoin payouts

The New Gold Trade Dominating on Wall Street - Ad

Wall Street has been making headlines lately for piling into gold. According to Dr. David Eifrig, the gold bull run is just getting started. He says you should move your money to his No. 1 gold stock immediately (not a miner or ETF but it has 1,000% upside potential.)

FAA says flight cuts will stay at 6% because more air traffic controllers are coming to work

WASHINGTON (AP) — Flight reductions at 40 major U.S. airports will remain at 6% instead of rising to 10% by the end of the week because more air traffic controllers are coming to work, the Department of Transportation and the Federal Aviation Administration announced Wednesday.

Wall Street Enters Its Strongest Month: These 7 Stocks Often Crush It

November is historically Wall Street's strongest month. These 7 stocks often delivered standout gains in recent decades.

Another Gold High? Here's the Move Wall Street Is Missing ... - Ad

Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.

FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical

The U.S. Food and Drug Administration says drugmakers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.

Trump no-show at big Asian economic forum may risk US reputation in region

GYEONGJU, South Korea (AP) — A hot mike caught U.S. President Donald Trump saying that his much-anticipated meeting Thursday , meant to settle the most important trade relationship in the world, would be “three, four hours” and he would then fly back to Washington.

Why Wall Street Is Piling Into the "Debasement Trade" - Ad

Wall Street has been making headlines lately for piling into a strange new money move. What they've dubbed the "Debasement Trade"... And it could affect you and your money in a MAJOR way. Dr. David Eifrig's latest warning deserves your attention.

Dave Ramsey Reveals Why Millionaires Crush Mortgages Early

Dave Ramsey advises buying a home with cash, citing his firm's survey of millionaires who often retire their mortgages in about 10 years.

America's Next Security Revolution Has Begun - Ad

Built for endurance, powered by AI, and proven in the field, the K7 is redefining protection for ports, energy hubs, and cities across the nation. The rollout is already underway.

AMD, Oklo, AppLovin Corp, Viking Therapeutics And Novo Nordisk: Why These 5 Stocks Are On Investors' Radars Today

Major U.S. indices closed mixed on Tuesday, with the Dow Jones Industrial Average climbing 1.2% to 47,927.96 and the S&P 500 inching up 0.2% to 6,846.61.

After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad

For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.

Nvidia Packaging Partner Amkor Logs Momentum Gain— Up Over 30% YTD On AI Surge

Amkor Technologies (AMKR) hits top momentum percentile, up over 30% YTD as Nvidia's key CoWoS/HBM partner. AI surge drives gains.

Toyota Fuels US Workforce With $14 Billion Battery Plant

Toyota starts U.S. battery production, unveils $10B extra investment and a $14B North Carolina hub slated for 5,100 jobs.

This Overlooked Memecoin Is Showing Early Breakout Signals - Ad

We've been tracking one small memecoin that checks all the boxes: strong on-chain signals, real traction, and an entry point that could offer serious upside. It's not on many radars yet-but that could change fast.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service